Volume 13, Issue 2 (volume 13, number 2 2021)                   IJDO 2021, 13(2): 109-112 | Back to browse issues page

XML Print

Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Imanipour S, Imanipour V. How is the Effect of Physical Activity on Non-Alcoholic Fatty Liver in Obese People? A Mini Review. IJDO 2021; 13 (2) :109-112
URL: http://ijdo.ssu.ac.ir/article-1-633-en.html
PhD, Department of Physical Education and Sport Sciences, Parand Branch, Islamic Azad University, New city of Parand, Iran.
Abstract:   (760 Views)
Nonalcoholic fatty liver is known in the general public as an epidemic disease. The purpose of this mini-review was to determine a link between physical education (PA) and the risk of nonalcoholic fatty liver disease (NAFLD) determine the influence of an exercise method (volume and kind of exercise) on being health outcome.
Body mass index (BMI) was the good criteria for classifying obesity. It is ranges from underweight (<18.5 kg/m2) to severe or unhealthy obesity (≥40 kg/m2). Most time exercise was sufficient to reduce advanced fibrosis in almost 50% including moderated aerobic exercise for 2.5–5 hours a week, or 1–2.5 hours a week on vigorous intense exercise.
Different intensities of physical activity is affected on fatty liver factors and volume and exercise method stimulate improvements in related health outcome measures in obese people. Prolonged inactivity time was increased the prevalence of NAFLD. The final results were shown the influence of PA at different intensities and volume on NAFLD. Then a healthy lifestyle can improve the quality of life and physical health.
Full-Text [PDF 349 kb]   (353 Downloads)    
Type of Study: Research | Subject: Special
Received: 2021/06/16 | Accepted: 2021/06/20 | Published: 2021/06/20

1. Younossi ZM, Koenig AB, Abdelatif D, Fazel Y, Henry L, Wymer M. Global epidemiology of nonalcoholic fatty liver disease-meta‐analytic assessment of prevalence, incidence, and outcomes. Hepatology. 2016;64(1):73-84. [DOI:10.1002/hep.28431]
2. Loria P, Lonardo A, Carulli L, Verrone AM, Ricchi M, Lombardini S, et al. the metabolic syndrome and non‐alcoholic fatty liver disease. Alimentary pharmacology & therapeutics. 2005;22:31-6. [DOI:10.1111/j.1365-2036.2005.02592.x]
3. Zhao G, Ford ES, Li C, Balluz LS. Physical activity in US older adults with diabetes mellitus: prevalence and correlates of meeting physical activity recommendations. Journal of the American Geriatrics Society. 2011;59(1):132-7. [DOI:10.1111/j.1532-5415.2010.03236.x]
4. Gerber L, Otgonsuren M, Mishra A, Escheik C, Birerdinc A, Stepanova M, et al. Non‐alcoholic fatty liver disease (NAFLD) is associated with low level of physical activity: a population‐based study. Alimentary pharmacology & therapeutics. 2012;36(8):772-81. [DOI:10.1111/apt.12038]
5. Maersk M, Belza A, Stodkilde-Jorgensen H, Ringgaard S, Chabanova E, Thomsen H, et al. Sucrose-sweetened beverages increase fat storage in the liver, muscle, and visceral fat depot: a 6-mo randomized intervention study. The American journal of clinical nutrition. 2012;95(2):283-9. [DOI:10.3945/ajcn.111.022533]
6. Sansone A, Sansone M, Vaamonde D, Sgro P, Salzano C, Romanelli F, et al. Sport, doping and male fertility. Reproductive Biology and Endocrinology. 2018;16(1):1-2. [DOI:10.1186/s12958-018-0435-x]
7. Perseghin G, Lattuada G, De Cobelli F, Ragogna F, Ntali G, Esposito A, et al. Habitual physical activity is associated with intrahepatic fat content in humans. Diabetes care. 2007;30(3):683-8. [DOI:10.2337/dc06-2032]
8. Younossi ZM, Stepanova M, Afendy M, Fang Y, Younossi Y, Mir H, et al. Changes in the prevalence of the most common causes of chronic liver diseases in the United States from 1988 to 2008. Clinical gastroenterology and hepatology. 2011;9(6):524-30. [DOI:10.1016/j.cgh.2011.03.020]
9. Wang Z, Xu M, Peng J, Jiang L, Hu Z, Wang H, et al. Prevalence and associated metabolic factors of fatty liver disease in the elderly. Experimental Gerontology. 2013;48(8):705-9. [DOI:10.1016/j.exger.2013.05.059]
10. Xu C, Yu C, Ma H, Xu L, Miao M, Li Y. Prevalence and risk factors for the development of nonalcoholic fatty liver disease in a nonobese Chinese population: the Zhejiang Zhenhai Study. American Journal of Gastroenterology. 2013;108(8):1299-304. [DOI:10.1038/ajg.2013.104]
11. Erdmann J, Kallabis B, Oppel U, Sypchenko O, Wagenpfeil S, Schusdziarra V. Development of hyperinsulinemia and insulin resistance during the early stage of weight gain. American Journal of Physiology-Endocrinology and Metabolism. 2008;294(3):E568-75. [DOI:10.1152/ajpendo.00560.2007]
12. Hruby A, Hu FB. The epidemiology of obesity: a big picture. Pharmacoeconomics. 2015;33(7):673-89. [DOI:10.1007/s40273-014-0243-x]
13. Donnelly JE, Blair SN, Jakicic JM, Manore MM, Rankin JW, Smith BK. Appropriate physical activity intervention strategies for weight loss and prevention of weight regain for adults. Medicine & Science in Sports & Exercise. 2009;41(2):459-71. [DOI:10.1249/MSS.0b013e3181949333]
14. Hu FB. Obesity and mortality: watch your waist, not just your weight. Archives of internal medicine. 2007;167(9):875-6. [DOI:10.1001/archinte.167.9.875]
15. Kistler KD, Brunt EM, Clark JM, Diehl AM, Sallis JF, Schwimmer JB. NASH CRN Research Group. Physical activity recommendations, exercise intensity, and histological severity of nonalcoholic fatty liver disease. The American journal of gastroenterology. 2011;106(3):460. [DOI:10.1038/ajg.2010.488]
16. Perk J, De Backer G, Gohlke H, Graham I, Reiner Z, Verschuren M, et al. European Guidelines on cardiovascular disease prevention in clinical practice (version 2012) The Fifth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of nine societies and by invited experts) Developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR). European heart journal. 2012;33(13):1635-701. [DOI:10.1093/eurheartj/ehs092]
17. Eckel RH, Jakicic JM, Ard JD, de Jesus JM, Houston Miller N, Hubbard VS, et al. 2013 AHA/ACC guideline on lifestyle management to reduce cardiovascular risk: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Journal of the American College of Cardiology. 2014;63(25 Part B):2960-84. [DOI:10.1016/j.jacc.2013.11.003]
18. Zelber‐Sagi S, Nitzan‐Kaluski D, Goldsmith R, Webb M, Zvibel I, Goldiner I, et al. Role of leisure‐time physical activity in nonalcoholic fatty liver disease: a population‐based study. Hepatology. 2008;48(6):1791-8. [DOI:10.1002/hep.22525]
19. Keating SE, Hackett DA, Parker HM, O'Connor HT, Gerofi JA, Sainsbury A, et al. Effect of aerobic exercise training dose on liver fat and visceral adiposity. Journal of hepatology. 2015;63(1):174-82. [DOI:10.1016/j.jhep.2015.02.022]
20. Ryu S, Chang Y, Jung HS, Yun KE, Kwon MJ, Choi Y, et al. Relationship of sitting time and physical activity with non-alcoholic fatty liver disease. Journal of hepatology. 2015;63(5):1229-37. [DOI:10.1016/j.jhep.2015.07.010]

Add your comments about this article : Your username or Email:

Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

© 2023 CC BY-NC 4.0 | Iranian Journal of Diabetes and Obesity

Designed & Developed by : Yektaweb